中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment

文献类型：期刊论文

作者Jiang, Zhidong1,2,3; Feng, Bo3,4; Zhang, Yumin5; Nie, Tianqing3; Liu, Hong3; Li, Jia3,4; Su, Haixia3; Zhang, Leike5; Zang, Yi1,2,3; Zhou, Yu1,2,3
刊名SIGNAL TRANSDUCTION AND TARGETED THERAPY
出版日期2023-05-22
卷号8期号:1页码:4
ISSN号2095-9907
DOI10.1038/s41392-023-01482-9
通讯作者Su, Haixia(suhaixia1@simm.ac.cn) ; Zhang, Leike(zhangleike@wh.iov.cn) ; Zang, Yi(yzang@lglab.ac.cn) ; Zhou, Yu(zhouyu@simm.ac.cn)
资助项目National Natural Science Foundation of China[82151219] ; National Natural Science Foundation of China[82130105] ; Strategic Priority Research Program of the Chinese Academy of Sciences[SIMM010109] ; Strategic Priority Research Program of the Chinese Academy of Sciences[SIMM010111] ; Qiusuo Outstanding Youth Project of Lingang Laboratory[LG-QS-202205-02]
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology
语种英语
出版者SPRINGERNATURE
WOS记录号WOS:000993835300002
源URL[http://119.78.100.183/handle/2S10ELR8/306602]  
专题中国科学院上海药物研究所
通讯作者Su, Haixia; Zhang, Leike; Zang, Yi; Zhou, Yu
作者单位1.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201203, Peoples R China
2.Lingang Lab, Shanghai 201203, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
4.Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
5.Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Megasci, State Key Lab Virol, Wuhan 430071, Peoples R China
推荐引用方式
GB/T 7714		 Jiang, Zhidong,Feng, Bo,Zhang, Yumin,et al. Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2023,8(1):4.
APA Jiang, Zhidong.,Feng, Bo.,Zhang, Yumin.,Nie, Tianqing.,Liu, Hong.,...&Zhou, Yu.(2023).Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment.SIGNAL TRANSDUCTION AND TARGETED THERAPY,8(1),4.
MLA Jiang, Zhidong,et al."Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment".SIGNAL TRANSDUCTION AND TARGETED THERAPY 8.1(2023):4.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。